Skip to main content
Clinical Trials/NCT01556542
NCT01556542
Completed
Phase 4

Drug Eluting Balloon in peripherAl inTErvention: the DEBATE SFA Study

Leonardo Bolognese, MD1 site in 1 country104 target enrollmentNovember 2010

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Peripheral Arterial Disease
Sponsor
Leonardo Bolognese, MD
Enrollment
104
Locations
1
Primary Endpoint
angiographic binary restenosis
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the efficacy of drug-eluting balloon angioplasty followed by nitinol stent implantation versus nitinol stent implantation in superficial femoral artery and popliteal artery stenosis.

Registry
clinicaltrials.gov
Start Date
November 2010
End Date
September 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Leonardo Bolognese, MD
Responsible Party
Sponsor Investigator
Principal Investigator

Leonardo Bolognese, MD

Director of Cardiovascular Department

Ospedale San Donato

Eligibility Criteria

Inclusion Criteria

  • age\>18 years
  • intermittent claudication(Fontane III or IV)
  • angiographic stenosis\>50% or occlusion of superficial femoral-popliteal artery\>40mm
  • at least one below-knee vessel to the ankle

Exclusion Criteria

  • allergy to Paclitaxel
  • contraindication for combined antiplatelet treatment
  • life expectancy \<1 year
  • hypersensitivity or contraindication to one of the study drugs
  • lack of consent

Outcomes

Primary Outcomes

angiographic binary restenosis

Time Frame: 12 months

incidence of binary restenosis

Secondary Outcomes

  • major amputation(24 months)
  • target lesion revascularization(24 months)
  • vessel reocclusion(24 months)

Study Sites (1)

Loading locations...

Similar Trials